According to the Zhitong Finance App, China Resources Pharmaceutical (03320) announced China Resources Shuanghe's results for the first three quarters of 2026. Total operating revenue was about 8.066 billion yuan, a decrease of 4% year on year; net profit was about 1,307 billion yuan, a decrease of 6.51% year on year.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.